La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Apomorphine And NotMarianna Armogida

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000392 M. Lafreniere-Roula [Canada] ; O. Darbin [États-Unis] ; W. D. Hutchison [Canada] ; T. Wichmann [États-Unis] ; A. M. Lozano [Canada] ; J. O. Dostrovsky [Canada]Apomorphine reduces subthalamic neuronal entropy in parkinsonian patients
000479 Atsuko Nagano-Saito [Canada] ; JIAQIANG LIU [Canada] ; Julien Doyon [Canada] ; Alain Dagher [Canada]Dopamine modulates default mode network deactivation in elderly individuals during the Tower of London task
000632 Jessica M. Castellano [Canada] ; Jody Batrynchuk [Canada] ; Kristine Dolbeare [États-Unis] ; Vaneeta Verma [Canada] ; Amandeep Mann [Canada] ; Kevin J. Skoblenick [Canada] ; Rodney L. Johnson [États-Unis] ; Ram K. Mishra [Canada]MIF-1 and its peptidomimetic analogs attenuate haloperidol-induced vacuous chewing movements and modulate apomorphine-induced rotational behavior in 6-hydroxydopamine-lesioned rats
000633 Jessica M. Castellano [Canada] ; Jody Batrynchuk [Canada] ; Kristine Dolbeare [États-Unis] ; Vaneeta Verma [Canada] ; Amandeep Mann [Canada] ; Kevin J. Skoblenick [Canada] ; Rodney L. Johnson [États-Unis] ; Ram K. Mishra [Canada]MIF-1 and its peptidomimetic analogs attenuate haloperidol-induced vacuous chewing movements and modulate apomorphine-induced rotational behavior in 6-hydroxydopamine-lesioned rats
000728 G. Rasouli [Canada] ; M. Rasouli [Canada] ; F. A. Lenz [États-Unis] ; L. Verhagen [États-Unis] ; D. S. Borrett [Canada] ; H. C. Kwan [Canada]Fractal characteristics of human parkinsonian neuronal spike trains
000A27 G. A. Metz [Canada] ; I. Q. Whishaw [Canada]Drug-induced rotation intensity in unilateral dopamine-depleted rats is not correlated with end point or qualitative measures of forelimb or hindlimb motor performance
000B35 Lana Depatie [Canada] ; Samarthji Lal [Canada]Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?
000B77 A. M. Lozano [Canada] ; A. E. Lang [Canada] ; R. Levy [Canada] ; W. Hutchison [Canada] ; J. Dostrovsky [Canada]Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine
000C60 V. D. Doan [Canada] ; R. Grondin [Canada] ; ABDALLAH HADJ TAHAR [Canada] ; L. Gregoire [Canada] ; P. J. Bedard [Canada]Effect of the selective D1 antagonists SCH 23390 and NNC 01-0112 on the delay, duration, and improvement of behavioral responses to dopaminergic agents in MPTP-treated monkeys
000C77 T. L. Sourkes [Canada]"Rational hope" in the early treatment of Parkinson's disease
000D86 W. D. Hutchison [Canada] ; R. Levy [Canada] ; J. O. Dostrovsky [Canada] ; A. M. Lozano [Canada] ; A. E. Lang [Canada]Effects of apomorphine on globus pallidus neurons in parkinsonian patients
000E14 N. Galvez-Jimenez [Canada] ; A. E. Lang [Canada]Perioperative problems in Parkinson's disease and their management : Apomorphine with rectal domperidone
001085 L. Tremblay ; M. Filion ; P. J. BedardResponses of pallidal neurons to striatal stimulation in monkeys with MPTP-induced parkinsonism

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022